More great news has been announced about CGM! The Dexcom G6 continuous glucose monitor (CGM) will be covered for Medicare beneficiaries, starting in early 2019. CGMs are DME items that provide critical information on blood glucose levels to help patients with diabetes better manage their disease. Coverage for therapeutic CGM includes certain beneficiaries who have either Type 1 or Type 2 diabetes and intensively manage their insulin.

The Dexcom G6 CGM shines because of the following advantages:

Zero fingersticks

Acetaminophen blocking to maintain accuracy while taking Tylenol

Smartphone app that allows data to be shared with family members, providers, and other members of a patient's care team

Super easy application device

Very small and discreet sensor

Integration with the tSlim:X2 insulin pump from Tandem Diabetes, which is also covered by Medicare